Drug Profile
RO 611790
Alternative Names: VML 588Latest Information Update: 15 Aug 2000
Price :
$50
*
At a glance
- Originator Roche
- Class Antispasmodics; Dioxanes; Neuroprotectants; Phenyl ethers; Pyridines; Pyrimidines; Small molecules; Sulfonamides; Tetrazoles
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal failure; Subarachnoid haemorrhage
Most Recent Events
- 15 Aug 2000 Discontinued-I for Renal failure in World (IV)
- 15 Aug 2000 Discontinued-I for Subarachnoid haemorrhage in World (IV)
- 24 May 2000 Vanguard Medica is now called Vernalis Group